Herbert Stoeger

Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · The Lancet Oncology · 2011 · 462 citations

Zoledronic Acid, Breast Oncology, Oncology +10

Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone

Michael Gnant, Martin Filipits, Richard Greil et al. · Annals of Oncology · 2013 · 392 citations · Full text

Surgical Oncology, Breast Oncology, Recurrence Score +10

Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12

Michael Gnant, Brigitte Mlineritsch, Herbert Stoeger et al. · Annals of Oncology · 2014 · 300 citations · Full text

Zoledronic Acid, Breast Oncology, Endocrine Oncology +12

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

Georg Pfeiler, Robert Königsberg, Christian Fesl et al. · Journal of Clinical Oncology · 2011 · 220 citations · Full text

Plasmapheresis reverses all side-effects of a cisplatin overdose – a case report and treatment recommendation

G Hofmann, Thomas Bauernhofer, Peter Krippl et al. · BMC Cancer · 2006 · 181 citations · Full text